Philip Morris International Korea expects that the U.S. Food and Drug Administration’s designation of IQOS, its heat-not-burn tobacco, as a modified risk tobacco product (MRTP) will prompt a change in the local tobacco regulations.

The FDA grants MRTP status to products that have demonstrated that is expected to benefit the population's health in general by reducing harmful or potentially harmful chemicals, PMI Korea said.